Clinical trials
Phase 1 Carcinoma, Transitional Cell trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Enrolling by invitation | 2 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Affiliated Hospital of Jiangnan University | 2 |
| Beijing Biotech | 1 |
| Huahui Health | 1 |
| Kinnate Biopharma | 1 |
| Pfizer | 1 |
| RemeGen Co., Ltd. | 1 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
| Shanghai Henlius Biotech | 1 |
| Shanghai Junshi Bioscience Co., Ltd. | 1 |
| Shanghai YingLi Pharmaceutical Co. Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 11 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Renal Cell | 3 |
| Colorectal Neoplasms | 3 |
| Melanoma | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Breast Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Stomach Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.